Financhill
Back

Oruka Therapeutics Stock Predictions

Oruka Therapeutics Stock Forecast

  • Is Oruka Therapeutics Stock Undervalued?
    The current Oruka Therapeutics [ORKA] share price is $20.50. The Score for ORKA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Oruka Therapeutics Stock Go Up Next Year?

Data Unavailable

Oruka Therapeutics Stock Rating

Data Unavailable

Oruka Therapeutics Stock Price History

Is ORKA stock going to rise?

  • The current trend is moderately bearish and ORKA is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:

52-Week Data

52-Week High:
31.13
52-Week Low:
19.57

Prediction Charts

Market Cap:
717.47M
Price in USD:
20.50
Volume:
274.35K
Beta:
0.00

Technical Analysis

SMA50:
26.24
SMA100:
0.00
SMA200:
0.00
52-Wk Change:
0%

Stock Predictions

  • Is Oruka Therapeutics stock public?
    Yes, Oruka Therapeutics is a publicly traded company.
  • What is the Oruka Therapeutics stock quote today?
    The Oruka Therapeutics stock price is 20.50 USD today.
  • How to buy Oruka Therapeutics stock online?
    You can buy Oruka Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-4 27.56 26.95 27.64 26.69
Nov-5 26.91 26.69 27.27 26.28
Nov-6 26.41 27.64 28.25 26.41
Nov-7 26.28 25.62 27.11 23.70
Nov-8 25.15 26.68 27.39 25.15
Nov-11 26.68 26.61 28.09 26.20
Nov-12 26.33 26.15 27.37 25.85
Nov-13 26.10 25.42 27.51 25.25
Nov-14 24.89 24.00 27.40 23.10
Nov-15 23.05 24.04 25.04 23.05
Nov-18 24.13 21.13 24.38 19.57
Nov-19 20.98 22.30 23.15 20.46
Nov-20 22.22 22.20 23.85 21.81
Nov-21 23.06 20.50 23.79 19.84

Oruka Therapeutics Earnings

Data Unavailable

Oruka Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.23 per share.

* Oruka Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.